Covid-19 roundup: AbbVie jumps into Covid-19 antibody hunt; AstraZeneca shoots for 2B doses of Oxford vaccine — with $750M from CEPI, Gavi
Another Big Pharma is entering the Covid-19 antibody hunt.
AbbVie has announced a collaboration with the Netherlands’ Utrecht University and Erasmus Medical Center and the Chinese-Dutch biotech Harbour Biomed to develop a neutralizing antibody that can treat Covid-19. The antibody, called 47D11, was discovered by AbbVie’s three partners, and AbbVie will support early preclinical work, while preparing for later preclinical and clinical development. Researchers described the antibody in Nature Communications last month.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.